Evidence map›Paper›PMID 25485589›Full record

ArticleCell cycle (Georgetown, Tex.)2014

The leukemia-associated Rho guanine nucleotide exchange factor LARG is required for efficient replication stress signaling.

Ryan D Beveridge, Christopher J Staples, Abhijit A Patil, Katie N Myers, Sarah Maslen, J Mark Skehel, Simon J Boulton, Spencer J Collis

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Ryan D Beveridgea Genome Stability Group ; Department of Oncology ; Academic Unit of Molecular Oncology ; University of Sheffield Medical School ; Sheffield , UK.
Christopher J Staples
Abhijit A Patil
Katie N Myers
Sarah Maslen
J Mark Skehel
Simon J Boulton
Spencer J Collis
Molecular Oncology (United States) · USUniversity of Sheffield · GBInstitute of Cell Biology · UAMRC Laboratory of Molecular Biology · GBRF Laboratories (United States) · US

Funding

Cancer Research UK 12102
6 · The paper itself

Abstract

We previously identified and characterized TELO2 as a human protein that facilitates efficient DNA damage response (DDR) signaling. A subsequent yeast 2-hybrid screen identified LARG; Leukemia-Associated Rho Guanine Nucleotide Exchange Factor (also known as Arhgef12), as a potential novel TELO2 interactor. LARG was previously shown to interact with Pericentrin (PCNT), which, like TELO2, is required for efficient replication stress signaling. Here we confirm interactions between LARG, TELO2 and PCNT and show that a sub-set of LARG co-localizes with PCNT at the centrosome. LARG-deficient cells exhibit replication stress signaling defects as evidenced by; supernumerary centrosomes, reduced replication stress-induced γH2AX and RPA nuclear foci formation, and reduced activation of the replication stress signaling effector kinase Chk1 in response to hydroxyurea. As such, LARG-deficient cells are sensitive to replication stress-inducing agents such as hydroxyurea and mitomycin C. Conversely we also show that depletion of TELO2 and the replication stress signaling kinase ATR leads to RhoA signaling defects. These data therefore reveal a level of crosstalk between the RhoA and DDR signaling pathways. Given that mutations in both ATR and PCNT can give rise to the related primordial dwarfism disorders of Seckel Syndrome and Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) respectively, which both exhibit defects in ATR-dependent checkpoint signaling, these data also raise the possibility that mutations in LARG or disruption to RhoA signaling may be contributory factors to the etiology of a sub-set of primordial dwarfism disorders.

Indexed as

Signal TransductionAntigensAtaxia Telangiectasia Mutated ProteinsCell SurvivalCentrosomeCheckpoint Kinase 1DNA RepairDNA ReplicationHCT116 CellsHEK293 CellsHeLa CellsHumansHydroxyureaMitomycinPhosphorylationProtein KinasesAntigensARHGEF12 protein, humanAtaxia Telangiectasia Mutated ProteinsATR protein, humanCheckpoint Kinase 1CHEK1 protein, humanHydroxyureaMitomycinpericentrinProtein KinasesrhoA GTP-Binding ProteinRho Guanine Nucleotide Exchange FactorsRNA, Small InterferingTelomere-Binding ProteinsATR signallingcentrosomeDDR, DNA damage responseDNA damage responseHU, hydroxyureaPCNT, pericentrinreplication stressRhoGEF

Identifiers

PMID25485589
PMCPMC4615130
OpenAlexW2058777299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.